Sweegen has announced that its Bestevia Rebaudiosides M (Reb M), D, and E have received full authorisation from the Taiwan FDA for use in food and beverages. This recent regulatory approval marks another milestone in Sweegen successfully opening new markets in countries where brands seek new generation stevia ingredients to expand their sugar reduction solutions.
Reb M, a steviol glycoside derived from the stevia plant, offers a clean and sugar-like taste profile. Sweegen’s Reb M technology offers several commercial advantages. Sweegen’s Signature Stevia starts with stevia, not GMO corn or sugar beets. The ingredient innovator utilises bioconversion technology to produce a range of zero-calorie sweeteners with assured quality, regulatory compliance, and competitive prices. These products generate a lower carbon footprint.
As Sweegen continues to excel in commercialisation and secures essential regulatory approvals in key markets like the EMEA and the UK, the company has witnessed substantial sales growth throughout 2023.
In addition to those critical regulatory approvals, Sweegen now offers its food and beverage manufacturing customers the right to use its Reb M in all non-alcoholic beverages anywhere in the world without infringing the relevant application patents. Customers already use Sweegen’s Reb M in other applications.
“At Sweegen, our focus revolves around safety, quality, and adherence to regulatory standards,” said Hadi Omrani, vice-president of technical and regulatory affairs. “We are expanding our global footprint by opening new markets to create access to innovative sweetener technologies.”
With increased interest from the global CPG companies and their desire for guaranteed capacity and supply chain redundancy, Sweegen has been working to establish and expand production facilities in major markets, including EMEA, North America, and APAC.
“The approval of Bestevia Reb M in Taiwan represents a breakthrough for brands aiming to create better-for-you foods and beverages,” said Casey McCormick, vice-president of global innovation. “Bestevia Reb M’s opens innovative avenues for reducing and even eliminating sugar, surpassing consumer expectations and contributing to public health goals aimed at curtailing sugar intake.”
Sweegen has recently achieved FEMA GRAS status for its sweet proteins, brazzein and thaumatin II, which serve as complements to steviol glycosides in the realm of food and beverage production. These sweet proteins assist food and beverage manufacturers in meeting the rising demand for better-for-you products. The brazzein technology is central to Sweegen’s newly launched Sweetensify flavors for taste modulation.
